Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 3, 2010, Pages 303-308

  Ashworth, Alan ^a   Webb, Stephen T ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Acute kidney injury; Cardiac surgery; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; CREATININE; PLACEBO; TROPONIN T;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HEART SURGERY; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LENGTH OF STAY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK REDUCTION; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT RESPONSE;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; AGED; BENCHMARKING; CARDIAC SURGICAL PROCEDURES; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; PROTECTIVE AGENTS; RENAL REPLACEMENT THERAPY; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957368732     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.232413     Document Type: Article

References (11)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact Cardiovasc Thorac Surg 2003;2:405-409.
2. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular surgeryassociated renal failure: a meta-analysis. Ann Thorac Surg 2009;87:139-147.
3. Adabag AS, Ishani A, Bloomfield HE, Ngo AK, Wilt TJ. Efficacy of Nacetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. Eur Heart J 2009;30:1910-1917.
4. Fischer UM, Tossios P, Mehlhorn U. Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin 2005;21:1161-1164.
5. Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, McFalls EO, Bloomfield HE, Chandrashekhar Y. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J 2008;155:1143-1149.
6. Sisillo E, Ceriani R, Bartone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 2008;36:81-86.
7. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, Matalanis G, Buxton B, Doolan L, Bellomo R. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007;35:1324-1331.
8. Ristikankare A, Kuitunen T, Kuitunen A, Uotila L, Vento A, Suojaranta-Ylinen R, Salmenpera M, Poyhia R. Lack of renoprotective effect of intravenous N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006;97:611-616.
9. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, Cartier R, Page P, Perrault LP. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blinded, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007;133:7-12.
10. Burns KEA, Chu MWA, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery. J Am Med Assoc 2005;294:342-350.
11. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anesth 2007; 54:872-881.